About Ignota Labs
Ignota Labs is a company based in London (United Kingdom) founded in 2021 by Layla Hosseini-Gerami and Sam Windsor.. Ignota Labs has raised $6.9 million across 1 funding round from investors including Montage Ventures, AIX Ventures and Modi Ventures. The company has 6 employees as of October 31, 2024. Ignota Labs offers products and services including SAFEPATH. Ignota Labs operates in a competitive market with competitors including Fagron, RareStone Group, Syntis, Pharmedium and Revelation Pharma, among others.
- Headquarter London, United Kingdom
- Employees 6 as on 31 Oct, 2024
- Founders Layla Hosseini-Gerami, Sam Windsor
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Absoluteai Ltd
- Date of Incorporation 14 Oct, 2021
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.9 M (USD)
in 1 rounds
-
Latest Funding Round
$6.9 M (USD), Seed
Feb 26, 2025
-
Investors
Montage Ventures
& 4 more
-
Employee Count
6
as on Oct 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ignota Labs
Ignota Labs offers a comprehensive portfolio of products and services, including SAFEPATH. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI model identifies and mitigates drug safety issues in trials.
Funding Insights of Ignota Labs
Ignota Labs has successfully raised a total of $6.9M through 1 strategic funding round. The most recent funding activity was a Seed round of $6.9 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $6.9M
-
First Round
First Round
(26 Feb 2025)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2025 | Amount | Seed - Ignota Labs | Valuation | Montage Ventures , AIX Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ignota Labs
Ignota Labs has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Montage Ventures, AIX Ventures and Modi Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US focused growth stage VC firm
|
Founded Year | Domain | Location | |
|
Venture capital is provided to AI-powered companies by AIX Ventures.
|
Founded Year | Domain | Location | |
|
Modi Ventures is focused on investments in tech-bio convergence.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ignota Labs
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ignota Labs
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ignota Labs Comparisons
Competitors of Ignota Labs
Ignota Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fagron, RareStone Group, Syntis, Pharmedium and Revelation Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug compounding services are provided by Fagron.
|
|
| domain | founded_year | HQ Location |
Provider of network and treatments to individuals and their families affected by rare diseases drugs
|
|
| domain | founded_year | HQ Location |
Drug compounding services are provided by Syntis in healthcare.
|
|
| domain | founded_year | HQ Location |
Drug compounding services are provided to healthcare facilities nationwide.
|
|
| domain | founded_year | HQ Location |
A network of compounding pharmacies is operated nationwide.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ignota Labs
Frequently Asked Questions about Ignota Labs
When was Ignota Labs founded?
Ignota Labs was founded in 2021 and raised its 1st funding round 4 years after it was founded.
Where is Ignota Labs located?
Ignota Labs is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Who is the current CEO of Ignota Labs?
Sam Windsor is the current CEO of Ignota Labs. They have also founded this company.
Is Ignota Labs a funded company?
Ignota Labs is a funded company, having raised a total of $6.9M across 1 funding round to date. The company's 1st funding round was a Seed of $6.9M, raised on Feb 26, 2025.
How many employees does Ignota Labs have?
As of Oct 31, 2024, the latest employee count at Ignota Labs is 6.
What does Ignota Labs do?
Ignota Labs is a technology startup in the pharmaceutical sector that provides AI-driven toxicity prediction tools for early-stage drug discovery scientists. Their suite of tools, TOXSCAPE, helps scientists identify and understand safety issues during the drug discovery process, reducing expensive setbacks and delays.
Who are the top competitors of Ignota Labs?
What products or services does Ignota Labs offer?
Ignota Labs offers SAFEPATH.
Who are Ignota Labs's investors?
Ignota Labs has 5 investors. Key investors include Montage Ventures, AIX Ventures, Modi Ventures, Blue Wire Capital, and Gaingels.